KTTA
Pasithea Therapeutics Corp. NASDAQ Listed Sep 15, 2021$0.84
Mkt Cap $6.3M
52w Low $0.28
31.4% of range
52w High $2.06
50d MA $0.78
200d MA $0.81
P/E (TTM)
-0.3x
EV/EBITDA
2.3x
P/B
0.1x
Debt/Equity
0.0x
ROE
-37.0%
P/FCF
-0.0x
RSI (14)
—
ATR (14)
—
Beta
0.25
50d MA
$0.78
200d MA
$0.81
Avg Volume
376.0K
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.
1111 LINCOLN ROAD, SUITE 500 · MIAMI BEACH, FL 33139 · US
Data updated apr 25, 2026 6:09pm
· Source: massive.com